Charter 1: Novel Clinical Trial End-points

Back

Charter 1: Novel Clinical Trial End-points

09.35
Why do we need better trial endpoints?
Professor Judith Bliss
09.55
Novel trial endpoints: Opportunities and challenges for new surrogate endpoints
Dr Marc Buyse
10.35
Discussion

Chairs: Professor Judith Bliss & Professor Nick Turner